176 related articles for article (PubMed ID: 10948160)
1. Impaired control of Brucella melitensis infection in Rag1-deficient mice.
Izadjoo MJ; Polotsky Y; Mense MG; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2000 Sep; 68(9):5314-20. PubMed ID: 10948160
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.
Pei J; Ding X; Fan Y; Rice-Ficht A; Ficht TA
Front Cell Infect Microbiol; 2012; 2():115. PubMed ID: 22973560
[TBL] [Abstract][Full Text] [Related]
3. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis.
Mense MG; Van De Verg LL; Bhattacharjee AK; Garrett JL; Hart JA; Lindler LE; Hadfield TL; Hoover DL
Am J Vet Res; 2001 Mar; 62(3):398-405. PubMed ID: 11277206
[TBL] [Abstract][Full Text] [Related]
4. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
Clapp B; Yang X; Thornburg T; Walters N; Pascual DW
Immunol Cell Biol; 2016 May; 94(5):496-508. PubMed ID: 26752510
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of immunopathophysiological responses induced by B. melitensis and its lipopolysaccharide in mouse model infected via intranasal route of exposure.
Osman AY; Saharee AA; Jesse FF; Kadir AA
Microb Pathog; 2017 Sep; 110():365-374. PubMed ID: 28710016
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.
Bhattacharjee AK; Van de Verg L; Izadjoo MJ; Yuan L; Hadfield TL; Zollinger WD; Hoover DL
Infect Immun; 2002 Jul; 70(7):3324-9. PubMed ID: 12065469
[TBL] [Abstract][Full Text] [Related]
7. B Cells Inhibit CD4
Dadelahi AS; Lacey CA; Chambers CA; Ponzilacqua-Silva B; Skyberg JA
Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32071068
[No Abstract] [Full Text] [Related]
8. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
[TBL] [Abstract][Full Text] [Related]
9. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of inhalational brucellosis in BALB/c mice.
Henning LN; Gillum KT; Fisher DA; Barnewall RE; Krile RT; Anderson MS; Ryan MJ; Warren RL
Sci Rep; 2012; 2():495. PubMed ID: 22773944
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.
Vitry MA; De Trez C; Goriely S; Dumoutier L; Akira S; Ryffel B; Carlier Y; Letesson JJ; Muraille E
Infect Immun; 2012 Dec; 80(12):4271-80. PubMed ID: 23006848
[TBL] [Abstract][Full Text] [Related]
12. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
13. Hepatic and splenic immune response during acute vs. chronic Brucella melitensis infection using in situ microscopy.
Daggett J; Rogers A; Harms J; Splitter GA; Durward-Diioia M
Comp Immunol Microbiol Infect Dis; 2020 Dec; 73():101490. PubMed ID: 33068875
[TBL] [Abstract][Full Text] [Related]
14. Identification of Immune Effectors Essential to the Control of Primary and Secondary Intranasal Infection with Brucella melitensis in Mice.
Hanot Mambres D; Machelart A; Potemberg G; De Trez C; Ryffel B; Letesson JJ; Muraille E
J Immunol; 2016 May; 196(9):3780-93. PubMed ID: 27036913
[TBL] [Abstract][Full Text] [Related]
15. Deletion of purE attenuates Brucella melitensis infection in mice.
Crawford RM; Van De Verg L; Yuan L; Hadfield TL; Warren RL; Drazek ES; Houng HH; Hammack C; Sasala K; Polsinelli T; Thompson J; Hoover DL
Infect Immun; 1996 Jun; 64(6):2188-92. PubMed ID: 8675325
[TBL] [Abstract][Full Text] [Related]
16. TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages.
Li Z; Fu Q; Wang Z; Li T; Zhang H; Guo F; Wang Y; Zhang J; Chen C
Lett Appl Microbiol; 2015 Jun; 60(6):565-71. PubMed ID: 25721466
[TBL] [Abstract][Full Text] [Related]
17. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
18. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
20. Course of infection with the emergent pathogen Brucella microti in immunocompromised mice.
Jiménez de Bagüés MP; de Martino A; Quintana JF; Alcaraz A; Pardo J
Infect Immun; 2011 Oct; 79(10):3934-9. PubMed ID: 21825066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
